biotech

Leveraged & Inverse Channel

Big Biopharma Mergers Could Fuel These ETFs in 2019

By Ben HernandezJanuary 10, 2019

Podcasts

ETF of the Week: Virtus LifeSci Biotech Clinical Trials ETF (BBC) 

By Brenton GarenSeptember 17, 2018

Equity ETFs

Pharma, Biotech Bull ETFs Leading the Charge

By Ben HernandezJuly 12, 2018

Equity ETFs

Semiconductor ETFs Face Technical Challenges

By Tom LydonApril 30, 2018

Equity ETFs

Big Biotech ETF Can Bounce Back

By Tom LydonApril 18, 2018

Investing

Try This ETF Pair to Round Out Biotech Exposure

By David DierkingMarch 23, 2018

Equity ETFs

Good Reasons to Stick With Biotech ETFs

By Tom LydonMarch 12, 2018

Equity ETFs

A Nifty Biotech ETF Idea for 2018

By Tom LydonJanuary 11, 2018

Equity ETFs

Biotech ETFs Struggle on Celgene Shock Waves

By Brenton GarenNovember 3, 2017

Equity ETFs

A Biotech Pullback Could be Afoot

By Brenton GarenOctober 26, 2017

Equity ETFs

Biotech ETFs Prescribe Investing Momentum

By Tom LydonJuly 24, 2017

Podcasts

Why Biotechnology Investing is Looking Healthy

By Brenton GarenJuly 6, 2017

Equity ETFs

Big Biotech ETF Bounce Looks for More Upside

By Brenton GarenJune 30, 2017

Equity ETFs

Biotech ETFs Could Heat Up Thanks to Republican-Led Congress

By Tom LydonJune 22, 2017

Equity ETFs

Encouraging Signs for a Big Biotech ETF

By Tom LydonMay 8, 2017

Equity ETFs

Biotech ETFs Look Promising as White House May Help FDA Expedite Drug Approvals

By Tom LydonMarch 10, 2017

Equity ETFs

Big Biotech Reaches Important Technical Juncture

By Tom LydonMarch 6, 2017

Equity ETFs

Buying Biotechnology Sector ETFs After U.S. Election Day

By Tom LydonOctober 25, 2016